These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 570995)

  • 21. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
    Clas F; Euteneuer B; Stemmer F; Loos M
    Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of [125I]C1q subcomponent for the measurement of complement binding antibodies on cell surfaces.
    Shepherd PS; Dean CJ
    J Immunol Methods; 1979; 25(1):55-60. PubMed ID: 422851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection.
    Kauffmann RH; Van Es LA; Daha MR
    J Immunol Methods; 1979; 31(1-2):11-22. PubMed ID: 390054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA; Steiger G; Schapira M
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium binding by troponin.
    Drabikowski W; Barylko B
    Acta Biochim Pol; 1971; 18(4):353-66. PubMed ID: 5139425
    [No Abstract]   [Full Text] [Related]  

  • 26. [The liquid phase C1q binding assay and its clinical application].
    Cheng PZ; Dong Y; Zhang NZ; Ji D; Dai X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of C1q with beta 2-microglobulin.
    Björck L; Johnson U; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
    Caillot G; Lamelin JP; Hartmann DJ; Ville G
    Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
    Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
    J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating immune complexes in breast cancer patients.
    Croce MV; Pasqualini RS; Segal-Eiras A
    Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
    [No Abstract]   [Full Text] [Related]  

  • 37. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin.
    Erdei A; Reid KB
    Biochem J; 1988 Oct; 255(2):493-9. PubMed ID: 3144267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The termination of immunologic unresponsiveness to the cyanogen bromide fragments of bovine serum albumin in rabbits.
    Benjamin DC; Hershey CW
    J Immunol; 1974 Nov; 113(5):1593-8. PubMed ID: 4138843
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction between Schistosoma mansoni and the complement system: binding of C1q to schistosomula.
    Santoro F; Ouaissi MA; Pestel J; Capron A
    J Immunol; 1980 Jun; 124(6):2886-91. PubMed ID: 6989909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.